Health plans to cover cervical cancer screening tests and subsequent diagnostic services requirement and appropriation
This bill requires all health insurance plans in Minnesota to cover pap tests and any necessary follow-up diagnostic services without cost-sharing (like copays or deductibles) for enrollees. It prohibits health plans from imposing referral requirements, utilization reviews, or quantity limits on these services. The state commissioner of commerce will reimburse insurers for the costs of this coverage starting in 2028, funded through annual appropriations from the general fund. The requirement applies to all health plans offered on or after January 1, 2027, directly affecting insurers and patients needing preventive cervical cancer screening.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 19, 2026
Last action Mar 9, 2026
Maddy AI version diff · 1 comparison
What changed between versions
Introduction
→
1st Engrossment
·
4 edits
·
Mar 9, 2026
MODERATE
The bill was updated from its introduction to its first engrossment version, expanding the scope of coverage from 'pap tests' to 'cervical cancer screening tests' to align with current medical guidelines. The changes clarify that coverage includes all tests recommended by the American Cancer Society and explicitly define follow-up diagnostic services, such as HPV exams and colposcopy, ensuring comprehensive care for abnormal results. This update strengthens the requirement for health plans to cover these services without quantity limitations, including specific rules on test frequency.
Scope change
The bill's scope broadened from covering only traditional pap tests to covering all cervical cancer screening tests recommended by the American Cancer Society, along with a more detailed definition of necessary follow-up diagnostic procedures.
DEFINITION
The term 'pap tests' was replaced with 'cervical cancer screening tests' to reflect modern medical terminology and guidelines.
REQUIREMENT
New language was added to explicitly include all cervical cancer screening tests recommended by the American Cancer Society Guideline at the time of service.
A detailed definition of 'additional diagnostic services' was added, specifying that it includes follow-up exams like HPV typing, cytology, dual stain, and colposcopy with biopsy to evaluate abnormalities.
The prohibition on quantity limitations was expanded to explicitly include limitations on test frequency, preventing insurers from restricting how often these tests can be performed.
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
1
Committee
2
Mar 9, 2026
Upper · Passed
Comm report: To pass as amended and re-refer to Health and Human Services
upper
Feb 19, 2026
Committee
Referred to Commerce and Consumer Protection
upper
Feb 19, 2026
Introduced
Introduction and first reading
upper
1 primary · 1 co-sponsor
Sponsors
Role
Legislator
Party
State
District
P
Alice Mann
DDemocratic-Farmer-Labor
Co
Liz Boldon
DDemocratic-Farmer-Labor
Ask Maddy
·
AI policy assistant
Ask Maddy about SF 3716
Scope: MN
Hi! I can help you understand SF 3716. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline